Categories: Uncategorized

Laurus Labs gets DRDO nod to make and market 2-Deoxy-D-glucose (2DG) in India

Laurus Labs announced that it has received the licence from Defence Research & Development Organisation (DRDO) to manufacture and market of 2-Deoxy-D-Glucose (2DG).

2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country.

Laurus Labs has already applied with CDSCO for emergency use authorization (EUA) for 2DG.

Medically Speaking Team

Recent Posts

THE HIDDEN CHALLENGE OF WEIGHT LOSS: HOW FAT CELLS “REMEMBER” OBESITY

Losing weight is a significant milestone, but for many, the bigger battle lies in keeping…

17 hours ago

LINDT CHOCOLATE CONTROVERSY: HEAVY METALS DISCOVERED IN POPULAR BRAND’S PRODUCTS

In recent months, a growing controversy has surfaced regarding the presence of heavy metals—specifically lead…

18 hours ago

THE SURPRISING BENEFITS OF VITAMIN B3 IN LOWERING DEATH RISK AND IMPROVING HEART HEALTH

A new study published in Scientific Reports has shed light on the potential benefits of dietary…

18 hours ago

WOMEN’S HEALTH: HOW EXCESS ZINC CAN DISRUPT MENSTRUAL CYCLE AND FERTILITY

Zinc is an essential mineral that plays a crucial role in maintaining overall health. Known…

20 hours ago

AIIMS- LED TRIAL FINDS OPTIMAL DRUG COMBINATION FOR HYPERTENSION PATIENTS

A groundbreaking clinical trial, spearheaded by a team of Indian and international experts, has shed…

20 hours ago

LINK BETWEEN COVID-19 INFECTION AND CANCER REGRESSION UNCOVERED IN A GROUNDBREAKING DISCOVERY

In an unprecedented discovery, scientists have uncovered a surprising connection between COVID-19 infections and the…

22 hours ago